ISPOR 2026 Home
  • About
    • News Center
  • Program
    • Program
    • Posters
    • Student Program
    • Learning Formats
    • Program Committee
    • Plenary Sessions
  • Exhibits & Sponsorship
    • Exhibitor Directory
    • Sponsors
    • Media Partners
  • Photo Gallery
large-circle

ISPOR 2026

Sunday, May 17 - Wednesday, May 20

  • Home
  • Events
  • Past Conferences
  • ISPOR 2026
  • Program
  • Program
  • Presentation
  • REAL-WORLD PERIOPERATIVE IMMUNOTHERAPY AND CELLULAR THERAPY IN OLDER ADULTS WITH SOLID TUMORS: A 2021-2025 MEDICARE-EMR LINKED ANALYSIS

    Mar 18, 2026, 21:38 PM
  • WHEN IS REAL-WORLD EVIDENCE SCIENTIFICALLY SOUND? EXPERT CONSENSUS ON SASS FOR CFL COMMUNICATION

    Mar 18, 2026, 21:38 PM
  • BLINATUMOMAB FOR FIRST RELAPSE OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A SINGLE-CENTER AMBISPECTIVE COHORT STUDY FROM CARTAGENA, COLOMBIA

    Mar 18, 2026, 21:38 PM
  • REAL-WORLD ROS1 TESTING IN FIRST-LINE NON-SMALL CELL LUNG CANCER

    Mar 18, 2026, 21:38 PM
  • SYSTEMATIC LITERATURE REVIEW OF PROGNOSTIC FACTORS AND TREATMENT EFFECT MODIFIERS IN NON-MUSCLE INVASIVE BLADDER CANCER

    Mar 18, 2026, 21:38 PM
  • PREFERENCES AND TRADE-OFFS FOR MASLD/MASH TESTING AMONG PATIENTS WITH TYPE 2 DIABETES: A DISCRETE CHOICE EXPERIMENT

    Mar 18, 2026, 21:38 PM
  • PREDICTING THE MAXIMUM FAIR PRICE (MFP) FROM THE SECOND ROUND OF MEDICARE NEGOTIATIONS

    Mar 18, 2026, 21:38 PM
  • REPOSITIONING HEOR AS A RISK MITIGATION TOOL FOR HEALTHCARE INVESTMENT DECISION-MAKING: GOOD VALUE FOR MONEY?

    Mar 18, 2026, 21:38 PM
  • THE IMPACT OF MEDICATION ADHERENCE ON REAL-WORLD CLINICAL AND ECONOMIC OUTCOMES: A SCOPING REVIEW OF REAL-WORLD EVIDENCE

    Mar 18, 2026, 21:38 PM
  • OBSERVED CARDIOVASCULAR DISEASE PREVALENCE AMONG OBESE AND TYPE 2 DIABETES PATIENTS WITH AND WITHOUT GLP-1 TREATMENT

    Mar 18, 2026, 21:38 PM
  • ECONOMIC IMPACT OF DIGITAL HEALTH SOLUTIONS: INSIGHTS FROM PETERSON HEALTH TECHNOLOGY INSTITUTE ASSESSMENTS

    Mar 18, 2026, 21:38 PM
  • COST-EFFECTIVENESS OF ROBOTIC-ASSISTED VERSUS LAPAROSCOPIC SURGERY FOR MID-LOW RECTAL CANCER: EVIDENCE FROM A MULTICENTER RANDOMIZED TRIAL IN CHINA

    Mar 18, 2026, 21:38 PM
  • A MULTI-AGENT GENAI SYSTEM FOR TRACEABLE, MULTI-COUNTRY LANDSCAPE ASSESSMENT IN MASH

    Mar 18, 2026, 21:38 PM
  • COST OF ILLNESS AMONG ALZHEIMER’S DISEASE AND RELATED DEMENTIAS (ADRD) MEDICARE PATIENTS IN THE UNITED STATES BETWEEN 2011-2021

    Mar 18, 2026, 21:38 PM
  • CHARACTERIZATION OF PATIENTS WITH PROSTATE CANCER IN COLOMBIA FROM A REAL-WORLD MULTICENTER FROM A HEALTHCARE RESOURCE UTILIZATION (HRU) STUDY

    Mar 18, 2026, 21:38 PM
  • ASSESSING SELF-REPORTED HEALTH AND QUALITY OF LIFE IN ETHNICALLY DIVERSE CAREGIVERS FOR PEOPLE WITH AGITATION IN ALZHEIMER'S DEMENTIA

    Mar 18, 2026, 21:38 PM
  • EFFICACY AND EFFECTIVENESS OF IMMUNE CHECKPOINT INHIBITORS IN TRIPLE-NEGATIVE BREAST CANCER: A SYSTEMATIC LITERATURE REVIEW

    Mar 18, 2026, 21:38 PM
  • ECONOMIC IMPACT OF AN AI-ENABLED DIGITAL TWIN INTERVENTION IN TYPE 2 DIABETES

    Mar 18, 2026, 21:38 PM
  • NATIONAL TRENDS IN OPIOID, BENZODIAZEPINE AND ANTICHOLINERGIC ORDERS IN LONG-TERM CARE

    Mar 18, 2026, 21:38 PM
  • UNDERSTANDING THE HUMANISTIC BURDEN OF SJÖGREN’S DISEASE (SJD): A SYSTEMATIC LITERATURE REVIEW (SLR)

    Mar 18, 2026, 21:38 PM
  • «
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27 (current)
  • 28
  • 29
  • 30
  • »
Quick Links

  • About
  • Media Center
  • Exhibits & Sponsorships
  • Contact Us
Policies & Legal

  • Antitrust Compliance
  • Code of Ethics
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy

Subscribe

Join ISPOR


ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group